Mice were treated with anti–PD-1 on days 2 and 9 after tumor induction and vaccinated with heat-shocked/γ-irradiated (hs/irr) tumor cells and the TLR7 agonist R848 on days 3 and 10 (Fig. 5 E). This evidence concerns the gene TLR7 and neoplasm.